Skip to main content
Log in

Randomized trial supports use of levetiracetam adjunctive therapy to treat partial seizures in children

  • Practice Point
  • Published:

From Nature Clinical Practice Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lynch BA et al. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101: 9861–9866

    Article  CAS  Google Scholar 

  2. Rogawski M (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69: 273–294

    Article  CAS  Google Scholar 

  3. Wang MM et al. (2003) Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina. J Comp Neurol 460: 106–122

    Article  CAS  Google Scholar 

  4. Stettler O et al. (1996) Differential synaptic vesicle protein expression in the barrel field of developing cortex. J Comp Neurol 375: 321–332

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frances E Jensen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jensen, F., Bourgeois, B. Randomized trial supports use of levetiracetam adjunctive therapy to treat partial seizures in children. Nat Rev Neurol 2, 596–597 (2006). https://doi.org/10.1038/ncpneuro0325

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0325

  • Springer Nature Limited

Navigation